Choroidal vasculature analysis in MEK inhibitor-associated retinopathy. Issue 6 (November 2022)
- Record Type:
- Journal Article
- Title:
- Choroidal vasculature analysis in MEK inhibitor-associated retinopathy. Issue 6 (November 2022)
- Main Title:
- Choroidal vasculature analysis in MEK inhibitor-associated retinopathy
- Authors:
- Cerquaglia, Alessio
Lupidi, Marco
Chhablani, Jay
Gujar, Ramkailash
Iaccheri, Barbara
Fiore, Tito
Fruttini, Daniela
Ramundo, Antonello
Vupparaboina, Kiran Kumar
Castellani, Luca
Simonetti, Edoardo
De Carolis, Luca
Tiacci, Enrico
Falini, Brunangelo
Cagini, Carlo - Abstract:
- Purpose: To evaluate choroidal vascularity index (CVI) in patients developing mitogen-activated protein kinase kinase (MEK) inhibitor-associated retinopathy (MEKAR). Methods: In this prospective observational study, extensive ophthalmic examination was performed, including enhanced-depth-imaging-optical coherence tomography (EDI-OCT). EDI-OCT scans of patients receiving Cobimetinib, taken at baseline and at MEKAR manifestation, were considered for choroid analysis. Choroidal thickness (CT) was measured on high-resolution b-scans passing through the fovea at three different locations. Same scans were therefore imported for binarization into a previously reported software and CVI was calculated as the ratio of luminal area (LA) to total choroid area (TCA). Results: When compared to baseline, eyes with MEKAR (14 eyes) did not show significative CT variation in subfoveal region (p = 0, 57), 750-µm-nasal to the fovea (p = 0, 08) and 750-µm-temporal to the fovea (p = 0, 07). Similarly, there were no statistically significant differences for TCA (p = 0.54), LA (p = 0.85), stromal area (SA) (p = 0.13), LA/SA (p = 0.34) and CVI (p = 0.47). Best-corrected visual acuity was significantly reduced at fluid accumulation when compared to baseline values (p = 0.03), with complete recovery after fluid resolution (p = 0.73). Conclusion: Multiple parameters reflecting the status of the choroid seemed not influenced by Cobimetinib administration. Retinal pigment epithelium toxic disfunctionPurpose: To evaluate choroidal vascularity index (CVI) in patients developing mitogen-activated protein kinase kinase (MEK) inhibitor-associated retinopathy (MEKAR). Methods: In this prospective observational study, extensive ophthalmic examination was performed, including enhanced-depth-imaging-optical coherence tomography (EDI-OCT). EDI-OCT scans of patients receiving Cobimetinib, taken at baseline and at MEKAR manifestation, were considered for choroid analysis. Choroidal thickness (CT) was measured on high-resolution b-scans passing through the fovea at three different locations. Same scans were therefore imported for binarization into a previously reported software and CVI was calculated as the ratio of luminal area (LA) to total choroid area (TCA). Results: When compared to baseline, eyes with MEKAR (14 eyes) did not show significative CT variation in subfoveal region (p = 0, 57), 750-µm-nasal to the fovea (p = 0, 08) and 750-µm-temporal to the fovea (p = 0, 07). Similarly, there were no statistically significant differences for TCA (p = 0.54), LA (p = 0.85), stromal area (SA) (p = 0.13), LA/SA (p = 0.34) and CVI (p = 0.47). Best-corrected visual acuity was significantly reduced at fluid accumulation when compared to baseline values (p = 0.03), with complete recovery after fluid resolution (p = 0.73). Conclusion: Multiple parameters reflecting the status of the choroid seemed not influenced by Cobimetinib administration. Retinal pigment epithelium toxic disfunction likely represents the crucial step in MEKAR pathogenesis. … (more)
- Is Part Of:
- European journal of ophthalmology. Volume 32:Issue 6(2022)
- Journal:
- European journal of ophthalmology
- Issue:
- Volume 32:Issue 6(2022)
- Issue Display:
- Volume 32, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 6
- Issue Sort Value:
- 2022-0032-0006-0000
- Page Start:
- 3564
- Page End:
- 3573
- Publication Date:
- 2022-11
- Subjects:
- choroid -- choroidal vascularity index -- MEK inhibitor-associated retinopathy -- retinal toxicity -- serous retinopathy
Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
617.7005 - Journal URLs:
- http://www.uk.sagepub.com/home.nav ↗
http://www.eur-j-ophthalmol.com/Home/Index ↗
http://journals.sagepub.com/home/ejo ↗ - DOI:
- 10.1177/11206721221081471 ↗
- Languages:
- English
- ISSNs:
- 1120-6721
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23575.xml